Case File
efta-02579650DOJ Data Set 11OtherEFTA02579650
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02579650
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Wednesday, January 22, 2014 11:20 AM
To:
Vinit Sahni
Subject:
Re: Jeffrey - Equity positioning survey and more (CI
thanks,
On Wed, Jan 22, 2014 at 4:07 AM, Vinit Sahni
<mailto
> wrote:
Classification: Co=fidential
Jeffrey - think flow of funds / positioning quite critical here as the market needs to shift from beta to alpha. The
below client positioning data within the institutional world doesn't surprise me, but highlights some trends /
dislocations. Especially in EM, staples, the fact that China remains the biggest concern yet very few hedge that risk, long
Europe trade= We are crunching some numbers here, to find the best medium to monetize some of the trades. Wanted
to highlight some key points from the survey
Jan contrarian trades: long bonds, short equities, long EM (brazil), short EU, long pharma, short insurance.
within stocks, biggest contrarian trade is long staples, short utilities=/u>
Rarely have we seen such bullish growth expectations, mixed with such bleak EM weightings - either EM ready
for a breakout or bullish growth expectations wrong
75% of investors expect a stronger global economy in next 12 months, this is a 3y high reading -> explains which
was market is skewed, 80% of them expectation below trend growth, therefore reluctant bulls
Sharp drop in China growth optimism in Jan (now 28% expecting weaker Chinese economy). expectations were
lower in mid-2013, therefore not a surprise.
2nd highest ever Net % saying US $ undervalue= (57%)
54% investors think EUR is overvalued, highest since early 2012
Equity investors say cash levels at 4.5% still quite high, different from the credit community. % of investors
saying equities are expensive (net 7%) at highest since Sep 2000, explains the high cash holdings
China hard landing biggest tail risk according to investors (trying to find the right tail risk hedge here)<=font>
Commodities still very underowned at 1.7 SD below its average
Allocation to US equities dips to net 6% overweight in Jan 2014, doesnt sound stretched
Net 15% of investors are underweight EM equities which is 2 50s below l0y average
Allocation to US equities stays high at 41% overweight, back to 2004-2007 levels
EFTA_R1_01754490
EFTA02579650
Allocation to staples falls to lowest level since aug 2003. Gap between long banks and short staples widest in
10yrs
Best
Vinit
Vinit Sahni
Managing Director I Global Head - Professional Client Group & Key Clien= Partners Capital Markets Group
Deutsche Asset & Wealth Management
105/108 Old Broad St (Pinners Hall),
EC2N 1EN London, United Kingdom
Tel.
Mobile
Email vinit
Any proposed ideas are being delivered to you by the DeAWM Key Client Partn=rs ("KCP") London desk for
discussion purposes only, and do not create any legally binding obligation on the part of Deutsche Bank AG and / or its
affiliates ("DB"). These ideas are for the consideration of the intended recipients of this mail only. The KCP London desk
does not provide investment advice. All intended recipients are Professional investors (as defined by MiFID), who
understand the strategy, characteristi=s and risks associated with any ideas proposed herein and will be able to evaluate
it independently. All trades on proposed ideas shall be subject to the relevant internal approvals prior to execution.
This e-mail may contain confidential and/or privileged information. If you =re not the intended recipient (or
have received this e-mail in error) plea=e notify the sender immediately and delete this e-mail. Any unauthorized
c=pying, disclosure or distribution of the material in this e-mail is strict=y forbidden.
Please refer to http://www.db.com/en/content/eu_disclosures.htm for =dditional EU corporate and regulatory
disclosures.
The information contained in this communication =s confidential, may be attorney-client privileged, may constitute
in=ide information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unau=horized
use, disclosure or copying of this communication or any part th=reof is strictly prohibited and may be unlawful. If you
2
EFTA_R1_01754491
EFTA02579651
have received t=is communication in error, please notify us immediately by return e-mail or=by e-mail to
[email protected] <[email protected]> , and destroy this communication and all copies t=ereof,
including all attachments. copyright -all rights reserved
3
EFTA_R1_01754492
EFTA02579652
Technical Artifacts (7)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Phone
2579650Phone
2579651Phone
2579652URL
http://www.db.com/en/content/eu_disclosures.htmRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.